SPR Therapeutics awarded $10 million from U.S. Department of Defense

SPR Therapeutics Inc., a Cleveland-headquartered medical device company, has been awarded two new grants and one new contract from the U.S. Department of Defense, totaling $10 million to further develop its non-opioid pain management therapy.

The therapy, SPR’s SPRINT Peripheral Nerve Stimulation (PNS) System, is FDA-cleared for the treatment of acute and chronic pain.

Click here to read the complete article.

Story excerpt provided by Crain’s Cleveland Business.

Written by Lydia Coutré.

Originally published October 3, 2018.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: